Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Asthenia
ADR ID BADD_A00362
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.01      Asthenic conditions
08.01.01.001      Asthenia
Description Clinical sign or symptom manifested as debility, or lack or loss of strength and energy. [MeSH]
MedDRA Code 10003549
MeSH ID D001247; D009440; D000073496
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Adynamia | Asthenia | Collapse of legs | Debility | Debility marked | Debility, unspecified | Feeling of total lack of energy | Feelings of weakness | General debility | Loss of energy | Nervous debility | Neurasthaenia | Neurasthenia | Strength loss of | Weakness | Weakness generalised | Weakness generalized | Weakness postural | Energy decreased | Frailty | Weakness worsened | Hyposthenia | Cerebro-asthenic syndrome
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02235Tocophersolan--
BADD_D02236Tofacitinib--
BADD_D02238Tolazamide--
BADD_D02240Tolbutamide--
BADD_D02241Tolcapone--
BADD_D02242Tolmetin sodium--
BADD_D02244Tolterodine--
BADD_D02245Tolterodine tartrate--
BADD_D02246Tolvaptan--
BADD_D02247Topiramate--
BADD_D02248Topotecan--
BADD_D02249Topotecan hydrochloride--
BADD_D02250Toremifene citrate--
BADD_D02251Torsemide0.000614%
BADD_D02252Tositumomab--
BADD_D02253Trabectedin0.001914%
BADD_D02254Tramadol--
BADD_D02255Tramadol hydrochloride--
BADD_D02256Tramazoline--
BADD_D02257Trametinib--
BADD_D02258Trametinib dimethyl sulfoxide--
BADD_D02259Trandolapril--
BADD_D02260Trandolaprilat--
BADD_D02261Tranexamic acid--
BADD_D02262Tranylcypromine--
BADD_D02263Tranylcypromine sulfate--
BADD_D02264Trastuzumab--
BADD_D02265Travoprost--
BADD_D02266Trazodone0.000074%
BADD_D02267Trazodone hydrochloride--
The 41th Page    First    Pre   41 42 43 44 45    Next   Last    Total 47 Pages
ADReCS-Target
ADR Term Drug Name Target